Galectin-1 dimers can scaffold Raf-effectors to increase H-ras nanoclustering

Galectin-1 (Gal-1) dimers crosslink carbohydrates on cell surface receptors. Carbohydrate-derived inhibitors have been developed for cancer treatment. Intracellularly, Gal-1 was suggested to interact with the farnesylated C-terminus of Ras thus specifically stabilizing GTP-H-ras nanoscale signalling...

Descripción completa

Detalles Bibliográficos
Autores principales: Blaževitš, Olga, Mideksa, Yonatan G., Šolman, Maja, Ligabue, Alessio, Ariotti, Nicholas, Nakhaeizadeh, Hossein, Fansa, Eyad K., Papageorgiou, Anastassios C., Wittinghofer, Alfred, Ahmadian, Mohammad R., Abankwa, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834570/
https://www.ncbi.nlm.nih.gov/pubmed/27087647
http://dx.doi.org/10.1038/srep24165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834570/
https://www.ncbi.nlm.nih.gov/pubmed/27087647
http://dx.doi.org/10.1038/srep24165

Ejemplares similares